EBERECHI KALU: Open Payments
NPI 1700290376 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 14 payments from 8 companies in 2025. Trend: 2023 $40 · 2024 $200 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Amgen Inc. | 1 | $28 |
| Exact Sciences Corporation | 2 | $28 |
| Astellas Pharma US Inc | 1 | $27 |
| Novo Nordisk Inc | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
Products named: REXULTI, KISUNLA, MOUNJARO, KRYSTEXXA, Cologuard Collection Kit, Veozah, Ozempic, ZEPBOUND.
Industry payments across GA — which companies pay providers there.
